Professor at McGill University and Director of the Magnetic Resonance Spectroscopy Unit in the Brain Imaging Center at the Montreal Neurological Institute and Hospital.
Dr. Arnold received his medical degree from Cornell University, USA. He completed his residency in Neurology at McGill University and a post-doctoral fellowship in Magnetic Resonance at the University of Oxford.
Dr. Douglas Arnold is a Professor in the Department of Neurology and Neurosurgery at McGill University, Director of the Magnetic Resonance Spectroscopy Unit in the Brain Imaging Center at the Montreal Neurological Institute and Hospital, and President of NeuroRx Research. He has special expertise in advanced MRI analysis techniques, particularly as they relate to understanding the evolution of multiple sclerosis and neurodegeneration.
Recipient of a $6.1 million grant since September 2016, Dr. Douglas Arnold will lead sixteen other investigators from around the world to develop next generation MRI biomarkers of clinical disease progression in progressive MS to be used as outcome measures in early phase (phase 2) trials.
Physiotherapist, MSc. PhD student, School of Physical & Occupational Therapy, McGill University
Vanessa Bouchard, MSc., is currently completing her PhD in Rehabilitation Science at McGill University. She has been practicing as a physiotherapist in hospital environment since 2009. Her doctoral research project focuses on improving the quality of life of people dealing with multiple sclerosis through self-management. She’s, with Nancy Mayo, PhD, co-author of the book Getting On With Your Life With MS that will be published shortly, in which several physicians and MS expert researchers have collaborated. This book is intended to help people with MS take charge of their health despite MS.
Professor of Neurology at the Université de Montréal and founder director of the Notre-Dame MS Clinic (CHUM).
Dr. Pierre Duquette attended the Université de Montréal where he completed his Medical Doctorate in 1969. He is a certified neurologist and a fellow of the Royal College of Physicians and Surgeons of Canada since 1973. He completed his subspecialty training, as a research and clinical fellow at University of California, Los Angeles.
Dr. Pierre Duquette is a Professor of Neurology at the Université de Montréal. He is the founder and current director of the Notre-Dame MS Clinic (CHUM), which has been operating since 1976. This clinic is devoted to the global management of MS patients, as well as to research on MS.
His main research interests include various aspects of the genetics, immunology and epidemiology of MS. He has participated in multiple clinical trials on new drugs. He is also interested in amyotrophic lateral sclerosis (ALS).
Elizabeth Gowing is a doctoral student in the lab of Dr. Alexandre Prat at the CRCHUM in Montreal. In 2013 she completed a First Class Honours Bachelor of Science degree from McGill University, where she worked with Dr. Alyson Fournier and Dr. Amit Bar-Or, studying neuroregeneration and the immunopathology of MS, respectively.
As a doctoral student supported by the MS Society of Canada and the Fonds de recherche du Québec-Santé, she now studies mechanisms by which pathogenic immune cell subsets enter the central nervous system in MS. Elizabeth’s mother has had very active MS for 28 years. This personal connection to the disease, as well as her interactions with other MS patients and their loved ones, continues to motivate Elizabeth in her research endeavours.
Neurologist, assistant clinical professor and researcher at the CHUM research centre.
Dr. Catherine Larochelle obtained a medecine degree in 2004 from Université Laval. She completed her Neurology residency training at Université de Montréal in 2009, before completing a PhD degree in 2014 in the laboratory of Dr Alexandre Prat, working on adhesion molecules implicated in recruitment of pathogenic T cells in central neuroinflammation. She has then conducted a post-doctoral fellowship at the Universitätmedizin Mainz, Germany, under the supervision of Dr Frauke Zipp, focusing on interactions between immune cells and central neuroglial cells in vitro and in vivo. Since 2013 she is a staff neurologist at the Centre Hospitalier de l’Université de Montréal (CHUM), and since 2016 is an assistant clinical professor and a researcher at the CHUM research centre.
Director of the Clinical Research Unit (CRU) and Director of the Amyotrophic Lateral Sclerosis (ALS) Clinical Research Program at the Montreal Neurological Institute and Hospital.
Dr. Angela Lily Genge completed her medical degree at the Memorial University of Newfoundland and obtained her Internal Medicine and Neurology degrees in Canada and in the United-States prior to completing a fellowship in neuromuscular diseases at McGill University. She joined the staff of the Montreal Neurological Institute and Hospital in 1994 and was appointed Director of the CRU in 2004. She also became Director of the ALS Clinic in 1998.
Her interest in clinical research began while still a resident in Neurology. She began assisting Dr. Gordon Francis, the founding director of the CRU at the Montreal Neurological Institute and Hospital, in early trials in both multiple sclerosis and NeuroAIDS. The clinical research unit develops and executes over 100 clinical trials in various neurological conditions with an emphasis on ALS, MS, Neuromuscular diseases and primary brain tumors. Most recently Dr. Genge has been part of the development of the Biobank initiative of the Montreal Neurological Institute and Hospital.
Research Specialist at the Multiple Sclerosis Society of Canada.
Since 2015, Peter Schwarz-Lam is a Research Specialist at the Multiple Sclerosis Society of Canada. In his role, he oversees research operations and provides scientific support to research communications for the MS Society Research Department. His responsibilities include overseeing the administration of the research grant and award programs, including operating grants, trainee awards, collaborative grants, and other funding opportunities. This includes overseeing grant tracking and payments, developing and revising policies, and managing the grant review process.
Also, he is responsible for communicating key information about the MS Society’s research programs as well as breakthroughs in MS-related research to various stakeholders, including people affected by MS, donors, researchers, and the general public.
Director of the Division of Pediatric Neurology at the Montreal Children’s Hospital and Professor at McGill University.
Dr. Guillaume Sébire is a medical specialist in pediatric neurology and a researcher. He holds a doctorate in neurosciences from the Université de Paris VI. His research explores the interface between nervous and immune systems, particularly the role of certain components of inflammation in several childhood diseases: brain damage resulting from prematurity, cerebral palsy, multiple sclerosis and cerebrovascular strokes . Dr. Sébire's work focuses on understanding the causes of these diseases and developing new neuroprotective treatments. His laboratory is part of the Research Institute of the McGill University Health Center.
He assumed clinical, academic and administrative responsibilities as head of pediatric neurology at the university hospital of the Université catholique de Louvain (Belgium) from 1997 to 2002 and then at the Centre hospitalier universitaire de l'Université de Sherbrooke for nine years.
Did you know?
The MS Society consulted people with MS across the country to find out which research areas they considered to be most important. Here are the top five priorities identified: cause of MS, repair/remyelination, lifestyle changes, progressive MS and diagnosis (tied), and cognition and mental health.